NCT03190382View on ClinicalTrials.gov

SHOWME-PAD (Peripheral Artery Disease)

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 24, 2017

Primary Completion Date

September 30, 2023

Study Completion Date

April 1, 2024

Conditions
Peripheral Artery Disease
Interventions
OTHER

Decision Support Tool

Patients enrolled in the study will receive the decision tool prior to the first PAD clinic visit and the medical decision making conversation with the provider.

Trial Locations (1)

64111

Saint Luke's Hospital of Kansas City, Kansas City

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Saint Luke's Health System

OTHER

NCT03190382 - SHOWME-PAD (Peripheral Artery Disease) | Biotech Hunter | Biotech Hunter